HB 1360 - Public Health - Abortion-Inducing Drugs

HB 1360 - Public Health - Abortion-Inducing Drugs

Position: Support

Committee: House Health and Government Operations

The Catholic Conference represents the public policy interests of the three (arch)dioceses serving Maryland, the Archdioceses of Baltimore and Washington, D.C., and the Diocese of Wilmington, which together encompass over one million Marylanders.

HB 1360 would provide for the circumstances under and the manner in which a person may provide an abortion–inducing drug to a pregnant woman and establish reporting requirements related to the use of abortion–inducing drugs in the State.

The bill targets mail-order prescriptions of abortion-inducing drugs authorized by the federal Food and Drug Administration last year in response to the coronavirus pandemic.  These drugs were never intended to be provided without the direct involvement of a health-care worker or provided via mail.  An estimated 27.000 American women went to a hospital emergency room last year reporting complications from taking an abortion-induced drug.

Unfortunately, there are far too many abortionists who are willing to mail out abortion-inducing drugs without ever seeing a patient, even on video.  As a State we can and should do better and find ways to protect women. 

It is for these reasons that the Maryland Catholic Conference respectfully urges a favorable report for HB 1360.  Thank you for your consideration.